Fax: (206) 543-8136;
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Supplement
You have full text access to this OnlineOpen article
Guideline implementation for breast healthcare in low-income and middle-income countries†‡§
Overview of the Breast Health Global Initiative Global Summit 2007
Article first published online: 24 SEP 2008
DOI: 10.1002/cncr.23844
Published 2008 American Cancer Society
Issue
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Cancer
Supplement: Guidelines for International Breast Health and Cancer Control–Implementation
Volume 113, Issue Supplement 8, pages 2221–2243, 15 October 2008
Additional Information
How to Cite
Anderson, B. O., Yip, C.-H., Smith, R. A., Shyyan, R., Sener, S. F., Eniu, A., Carlson, R. W., Azavedo, E. and Harford, J. (2008), Guideline implementation for breast healthcare in low-income and middle-income countries. Cancer, 113: 2221–2243. doi: 10.1002/cncr.23844
- †
The Breast Health Global Initiative (BHGI) gratefully acknowledges grants and conference support from the following organizations and agencies: Fred Hutchinson Cancer Research Center; Susan G. Komen For The Cure; American Society of Clinical Oncology; US National Cancer Institute, Office of International Affairs; American Cancer Society; Lance Armstrong Foundation; US Agency for Healthcare Research and Quality (*Grant 1 R13 HS017218-01); US Centers for Disease Control and Prevention, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion; American Society of Breast Disease; Oncology Nursing Society; US National Cancer Institute, Office of Women's Health; US National Institutes of Health, Office of Research on Women's Health. In addition, the BHGI received unrestricted educational grants from AstraZeneca, Bristol-Myers Squibb, Ethicon Endo-Surgery, F. Hoffmann-La Roche, GE Healthcare, Novartis Oncology, and Pfizer Oncology.
- ‡
Complete financial disclosures are presented at the end of this article.
- §
This article is a US Government work and, as such, is in the public domain in the United States of America.
Publication History
- Issue published online: 3 OCT 2008
- Article first published online: 24 SEP 2008
- Manuscript Accepted: 24 JUN 2008
- Manuscript Received: 10 JUN 2008
Funded by
- Fred Hutchinson Cancer Research Center
- Susan G. Komen For The Cure
- American Society of Clinical Oncology
- US National Cancer Institute, Office of International Affairs
- American Cancer Society
- Lance Armstrong Foundation
- US Agency for Healthcare Research and Quality. Grant Number: 1 R13 HS017218-01
- US Centers for Disease Control and Prevention, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion
- American Society of Breast Disease
- Oncology Nursing Society
- US National Cancer Institute, Office of Women's Health
- US National Institutes of Health, Office of Research on Women's Health
- AstraZeneca
- Bristol-Myers Squibb
- Ethicon Endo-Surgery
- F. Hoffmann-La Roche
- GE Healthcare
- Novartis Oncology
- Pfizer Oncology
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , Author’s specialty and conflicts of interest contribute to conflicting guidelines for screening mammography, Journal of Clinical Epidemiology, 2012, 65, 7, 725
- 2
- 3, , , , , , Breast cancer in Brazil: present status and future goals, The Lancet Oncology, 2012, 13, 3, e95
- 4, , Current and emerging targeted therapies for metastatic breast cancer, Cancer, 2012, 118, 11Direct Link:
- 5, , Factors Influencing Axillary Lymph Node Metastasis in Invasive Breast Cancer, Asian Pacific Journal of Cancer Prevention, 2012, 13, 1, 251
- 6, , , , , , Impact of breast cancer patients' awareness on attendance at screening, International Nursing Review, 2012, 59, 2Direct Link:
- 7, , , , , , The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality, Cancer Epidemiology, 2012, 36, 3, 237
- 8, , Transfer of evidence-based medical guidelines to low- and middle-income countries, Tropical Medicine & International Health, 2012, 17, 2Direct Link:
- 9
- 10, , , , , , , , , , , , , , , , , Breast cancer management in low resource countries (LRCs): Consensus statement from the Breast Health Global Initiative, The Breast, 2011, 20, S3
- 11, , , , , , , , , , , , , , , , , , , , Breast cancer management in middle-resource countries (MRCs): Consensus statement from the Breast Health Global Initiative, The Breast, 2011, 20, S12
- 12, Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all, The Lancet Oncology, 2011, 12, 3, 306
- 13, , , , , , Cytotoxicity and gene expression profiles of novel synthesized steroid derivatives as chemotherapeutic anti-breast cancer agents, Bioorganic & Medicinal Chemistry, 2011, 19, 22, 6860
- You have free access to this content14, , , , , , Global cancer statistics, CA: A Cancer Journal for Clinicians, 2011, 61, 2Direct Link:
- 15, , , , , , , Identifying important breast cancer control strategies in Asia, Latin America and the Middle East/North Africa, BMC Health Services Research, 2011, 11, 1, 227
- 16, , , Implementation science and breast cancer control: A Breast Health Global Initiative (BHGI) perspective from the 2010 Global Summit, The Breast, 2011, 20, S1
- 17, , , , , Improving Breast Cancer Control via the Use of Community Health Workers in South Africa: A Critical Review, Journal of Oncology, 2011, 2011, 1
- 18, , , , , , , , , Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010, The Lancet Oncology, 2011, 12, 4, 387
- 19, , , , , Patterns of seeking medical care among Egyptian breast cancer patients: Relationship to late-stage presentation, The Breast, 2011, 20, 6, 555
- 20, , , , , , , , , , , , , , , , , , , Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative, The Breast, 2011, 20, S20
- 21, , , , , Quality varies across clinical practice guidelines for mammography screening in women aged 40–49 years as assessed by AGREE and AMSTAR instruments, Journal of Clinical Epidemiology, 2011, 64, 9, 968
- 22, , , , , , , , , , , , , , Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries, Annals of Oncology, 2011, 23, 4, 853
- 23, , , , , , , , , , , , , , Survey of utilization of multidisciplinary management tumor boards in Arab countries, The Breast, 2011, 20, S70
- 24, , , , , , , The role of breast cancer civil society in different resource settings, The Breast, 2011, 20, S81
- 25, , , , , , Treatment of metastatic breast cancer: State-of-the-art, subtypes and perspectives, Critical Reviews in Oncology/Hematology, 2011, 80, 3, 433
- 26
- 27, , Adjuvant Chemotherapy in Early-Stage Breast Cancer: What, When, and for Whom?, Surgical Oncology Clinics of North America, 2010, 19, 3, 649
- 28, , Balancing Resource Constraints against Quality of Care, World Journal of Surgery, 2010, 34, 11, 2537
- 29, BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications, Current Opinion in Obstetrics and Gynecology, 2010, 22, 1, 72
- 30, , , , Breast Cancer in Developing Countries: Opportunities for Improved Survival, Journal of Oncology, 2010, 2010, 1
- 31, , , , , , , , , Breast cancer in Latin America: Experts perceptions compared with medical care standards, The Breast, 2010, 19, 1, 50
- 32, , , , Breast Cancer in Low- and Middle-Income Countries: An Emerging and Challenging Epidemic, Journal of Oncology, 2010, 2010, 1
- 33, , , , , , , , Complex care systems in developing countries, Cancer, 2010, 116, 3Direct Link:
- 34, , , , Factors associated with low screening for breast cancer in the Palestinian authority, Cancer, 2010, 116, 19Direct Link:
- 35, , Must Breast Care Delivery Models from Resource Rich Environments Be Applied to Resource Limited Environment: Reply, World Journal of Surgery, 2010, 34, 11, 2784
- 36, , , , , , , , , Perception of anesthesia safety and postoperative symptoms of surgery patients in Ho Chi Minh City, Vietnam: a pioneering trial of postoperative care assessment in a developing nation, Environmental Health and Preventive Medicine, 2010, 15, 6, 333
- 37, , , , , , , , , , , , Potential Biomarker of L-type Amino Acid Transporter 1 in Breast Cancer Progression, Nuclear Medicine and Molecular Imaging, 2010, 45, 2, 93
- 38, , , Surgical Mammography Reporting in a Limited Resource Environment, World Journal of Surgery, 2010, 34, 11, 2530
- 39, , , , , , , , Use of Antidepressants in Patients with Breast Cancer Taking Tamoxifen, Journal of Breast Cancer, 2010, 13, 4, 325
- 40
- 41, Delivering consensus from the Asian Oncology Summit 2009, The Lancet Oncology, 2009, 10, 11, 1029
- 42, , , , , , , , First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009, The Lancet Oncology, 2009, 10, 11, 1102
- 43, , , , , , , , , , , , , , , , , , Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009, The Lancet Oncology, 2009, 10, 11, 1119
- 44, , , , , , , , , , , , Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009, The Lancet Oncology, 2009, 10, 11, 1111
- 45, , , , , , , , , Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009, The Lancet Oncology, 2009, 10, 11, 1077
- 46, , , , , , Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009, The Lancet Oncology, 2009, 10, 11, 1093
- 47, , , , , , , , , , , , , Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009, The Lancet Oncology, 2009, 10, 11, 1086
- 48, , , , , , , , , , Guideline implementation for breast healthcare in low- and middle-income countries, Cancer, 2008, 113, S8Direct Link:
- 49, , , , , , Locally advanced breast cancer, Cancer, 2008, 113, S8Direct Link:
- 50, Private Practice Pathology, Breast Care, and Economics, Seminars in Breast Disease, 2008, 11, 3, 129
- 51, , , , , , , Toremifene versus tamoxifen for advanced breast cancer, The Cochrane Library,Direct Link: